Open AccessOncourologist’s opinion on the results of the CARMENA study
Author(s) -
М. И. Волкова
Publication year - 2019
Publication title -
zlokačestvennye opuholi
Language(s) - English
Resource type - Journals
eISSN - 2587-6813
pISSN - 2224-5057
DOI - 10.18027/2224-5057-2018-8-4-26-29
Subject(s) - medicine , nephrectomy , renal cell carcinoma , intensive care medicine , oncology , surgery , general surgery , medical physics , kidney
Recently published results of CARMENA study seem to eliminate cytoreductive nephrectomy from current recommendations on the treatment of metastatic renal cell carcinoma patients who are candidates for targeted antiangiogenic therapy. The article is devoted to the critical analysis of the CARMENA trial and review of previously published data. Taking into account available data cytoreductive nephrectomy should be still performed in carefully selected patients.